Also found in: Thesaurus, Medical, Encyclopedia, Wikipedia.


 (hĭ-mŏl′ĭ-sĭs, hē′mə-lī′sĭs)
The destruction or dissolution of red blood cells, with subsequent release of hemoglobin.

he′mo·lyt′ic (hē′mə-lĭt′ĭk) adj.


(hɪˈmɒl ə sɪs)

the breaking down of red blood cells with liberation of hemoglobin.
he•mo•lyt•ic (ˌhi məˈlɪt ɪk) adj.

hemolysis, haemolysis

the breaking down of erythrocytes with liberation of hemoglobin in the blood. — hemolytic, haemolytic, adj.
See also: Blood and Blood Vessels
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.hemolysis - lysis of erythrocytes with the release of hemoglobin
lysis - (biochemistry) dissolution or destruction of cells such as blood cells or bacteria


n. hemólisis, ruptura de eritrocitos con liberación de hemoglobina en el plasma;
immune ______ inmune;
venom ______ venenosa.


n hemólisis f
References in periodicals archive ?
Nine patients experienced Grade 3 treatment-related adverse events: hypertriglyceridemia, hemolytic anemia and hemolysis, dizziness, headache, left renal cell carcinoma and insomnia.
In the study, voxelotor provided a rapid, statistically significant and sustained improvement in hemoglobin levels and reduced the incidence of worsening anemia and hemolysis.
Hemolysis is conventionally defined as the release of hemoglobin and other intracellular components of erythrocytes into the extracellular space of blood.
The American Academy of Pediatrics (AAP) recommends to measure bilirubin levels within 24 hours after cessation of phototherapy only in cases caused by hemolysis or in those who needed phototherapy in the first three to four days of life (2).
Keywords: Aneurysmal sub aortic perimembranous,Device embolisation, Heart block,Intravascular hemolysis, Nit-Occlud (PFM) detachable Coils, Percutaneous occlusion, Ventricular septal defect.
- The US Food and Drug Administration has approved Ultomiris (ravulizumab-cwvz), the first and only long-acting C5 complement inhibitor administered every eight weeks, for the treatment of adult patients with paroxysmal nocturnal hemoglobinuria, a debilitating ultra-rare blood disorder characterized by complement-mediated destruction of the red blood cells (hemolysis), US-based Alexion Pharmaceuticals, Inc.
The product is a long-acting complement inhibitor that prevents hemolysis. The efficacy of the product was studied in a clinical trial of 246 patients who earlier had not been treated for paroxysmal nocturnal hemoglobinuria (treatment naive), and whom were randomised to be treated with Ultomiris or eculizumab - the current standard.
It increases hemoglobin F concentrations, which decreases HgbS concentration and prevents HgbS polymerization, which in turn decreases RBC sickling and hemolysis. (1,5) Additional effects include inhibiting white blood cell and platelet production, which may ameliorate occlusive episodes.
Blood samples from a consenting healthy volunteer meeting the inclusion criteria were collected in BD vacutainer heparin tubes (Vacutainer 367871, Mexico DF, Mexico) for hemolysis assays, and in BD Vacutainer EDTA tubes (Vacutainer 368171) for fibrinogen quantification assays.To maintain homogeneity, 3 mL of blood was collected for all samples.
In warm antibody AIHA, IgG type antibodies bind to erythrocyte surfaces at 37 [degrees]C and cause mostly splenic hemolysis and extravascular hemolysis.
The acronym HELLP was coined by Weinstein in 1982 to describe a syndrome consisting of Hemolysis, Elevated Liver enzymes & Low Platelet count.
The other main type of compatibility test, the DAT, is typically used to diagnose causes of hemolysis, such as transfusion-related hemolysis, hemolytic disease of the fetus and newborn, autoimmune hemolytic anemia, and drug-induced immune hemolysis.